1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Castleman Disease: new trials by email Literature Review of Castleman Disease trials Research Report on Castleman Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tocilizumab for KSHV-Associated Multicentric Castleman Disease Zidovudine, Tocilizumab, Valganciclovir (VGC) - Castleman Disease, Multicentric Castleman Disease | Phase 2 | Completed | National Cancer Institute (NCI) | 8 | 2011-09-13 | 2020-10-27 |
Acquired Immunodeficiency Syndrome (1) · Multi-centric Castleman's Disease (1) · Sarcoma, Kaposi (1)
Blood-Borne Infections (1) · Communicable Diseases (1) · DNA Virus Infections (1) · Genital Diseases (1) · HIV Infections (1) · Hemic and Lymphatic Diseases (1) · Herpesviridae Infections (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Immunoproliferative Disorders (1) · Infections (1) · Lentivirus Infections (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms (1)
Valganciclovir (1) · Zidovudine (1) · tocilizumab (1)
National Cancer Institute (NCI) (1)
United States (1)